Exact Mass: 646.4920616000002

Exact Mass Matches: 646.4920616000002

Found 500 metabolites which its exact mass value is equals to given mass value 646.4920616000002, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

SM(d18:1/12:0)

(2-{[(2S,3R,4E)-2-dodecanamido-3-hydroxyoctadec-4-en-1-yl phosphonato]oxy}ethyl)trimethylazanium

C35H71N2O6P (646.5049475999999)


Sphingomyelin (d18:1/12:0) or SM(d18:1/12:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. Sphingomyelin (d18:1/12:0) or SM(d18:1/12:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction.

   

DG(16:0/PGJ2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H66O7 (646.4808286)


DG(16:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propan-2-yl hexadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/PGJ2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H66O7 (646.4808286)


DG(16:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/0:0/16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propan-2-yl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/17:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/17:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,11Z,14Z)-O(8,9)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/17:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/17:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(8Z,11Z,14Z)-O(5,6)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/17:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl heptadecanoic acid

C40H70O6 (646.517212)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-3-(heptadecanoyloxy)-2-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-(Heptadecanoyloxy)-3-hydroxypropan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/17:0/0:0)

(2S)-2-(Heptadecanoyloxy)-3-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(17:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(17:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/17:0)

(2S)-3-(Heptadecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propan-2-yl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-17:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-17:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,11Z,14Z)-O(8,9)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-17:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-17:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(8Z,11Z,14Z)-O(5,6)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 14-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-17:0/0:0)

(2S)-3-hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-17:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-hydroxy-3-[(14-methylhexadecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoate

C40H70O6 (646.517212)


DG(a-17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-17:0/0:0)

(2S)-3-hydroxy-2-[(14-methylhexadecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoate

C40H70O6 (646.517212)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-17:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(a-17:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-17:0)

(2S)-2-Hydroxy-3-[(14-methylhexadecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/PGJ2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(i-16:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/i-16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propan-2-yl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/PGJ2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(i-16:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/0:0/i-16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propan-2-yl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-17:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-17:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-17:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,11Z,14Z)-O(8,9)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-17:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-17:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(8Z,11Z,14Z)-O(5,6)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 15-methylhexadecanoic acid

C40H70O6 (646.517212)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-17:0/0:0)

(2S)-3-Hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-hydroxy-3-[(15-methylhexadecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoate

C40H70O6 (646.517212)


DG(i-17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-17:0/0:0)

(2S)-3-hydroxy-2-[(15-methylhexadecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoate

C40H70O6 (646.517212)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-17:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(i-17:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-17:0)

(2S)-2-Hydroxy-3-[(15-methylhexadecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C40H70O6 (646.517212)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   
   

ent-Kaur-16-en-15beta-yl ent-labda-8(17),13-dien-15-yl malonate

ent-Kaur-16-en-15beta-yl ent-labda-8(17),13-dien-15-yl malonate

C43H66O4 (646.4960836)


   

SM d30:1

SM d30:1

C35H71N2O6P (646.5049475999999)


Found in mouse brain; TwoDicalId=391; MgfFile=160720_brain_AA_18_Neg; MgfId=519 Found in mouse spleen; TwoDicalId=249; MgfFile=160729_spleen_DHA_12_Neg; MgfId=564

   

PE-Cer(d14:1/19:0)

N-(nonadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


   

PE-Cer(d15:1/18:0)

N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


   

PE-Cer(d14:2(4E,6E)/18:0(2OH))

N-(2-hydroxy-octadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine

C34H67N2O7P (646.4685642)


   

PE-Cer(d16:2(4E,6E)/16:0(2OH))

N-(2-hydroxy-hexadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine

C34H67N2O7P (646.4685642)


   

SM(d18:1/12:0)

N-lauroyl-D-erythro-Sphingosylphosphoryl choline

C35H71N2O6P (646.5049475999999)


   

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

C36H70O9 (646.5019570000001)


   

1-(O-alpha-D-galactopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

1-(O-alpha-D-galactopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

C36H70O9 (646.5019570000001)


   

1-(O-alpha-D-glucopyranosyl)-27-keto-(1,3R,29R)-triacontanetriol

1-(O-alpha-D-glucopyranosyl)-27-keto-(1,3R,29R)-triacontanetriol

C36H70O9 (646.5019570000001)


   
   

PA(O-16:0/17:1(9Z))

1-hexadecyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(O-18:0/15:1(9Z))

1-octadecyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(P-16:0/17:0)

1-(1Z-hexadecenyl)-2-heptadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(P-18:0/15:0)

1-(1Z-octadecenyl)-2-pentadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(P-20:0/13:0)

1-(1Z-eicosenyl)-2-tridecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA O-33:1

1-(1Z-octadecenyl)-2-pentadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

SM 30:1;O2

N-lauroyl-D-erythro-Sphingosylphosphoryl choline

C35H71N2O6P (646.5049475999999)


   

CerPE 33:1;O2

N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


   

CerPE 32:2;O3

N-(2-hydroxy-octadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine

C34H67N2O7P (646.4685642)


   

[(E)-2-(dodecanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

3-Demethylubiquinol-7

3-Demethylubiquinol-7

C43H66O4 (646.4960836)


   

DG(16:0/PGJ2/0:0)

DG(16:0/PGJ2/0:0)

C39H66O7 (646.4808286)


   

DG(PGJ2/16:0/0:0)

DG(PGJ2/16:0/0:0)

C39H66O7 (646.4808286)


   

DG(16:0/0:0/PGJ2)

DG(16:0/0:0/PGJ2)

C39H66O7 (646.4808286)


   

DG(PGJ2/0:0/16:0)

DG(PGJ2/0:0/16:0)

C39H66O7 (646.4808286)


   

DG(i-16:0/PGJ2/0:0)

DG(i-16:0/PGJ2/0:0)

C39H66O7 (646.4808286)


   

DG(PGJ2/i-16:0/0:0)

DG(PGJ2/i-16:0/0:0)

C39H66O7 (646.4808286)


   

DG(i-16:0/0:0/PGJ2)

DG(i-16:0/0:0/PGJ2)

C39H66O7 (646.4808286)


   

DG(PGJ2/0:0/i-16:0)

DG(PGJ2/0:0/i-16:0)

C39H66O7 (646.4808286)


   

DG(17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(17:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C40H70O6 (646.517212)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/17:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/17:0/0:0)

C40H70O6 (646.517212)


   

DG(17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(17:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C40H70O6 (646.517212)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/17:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/17:0)

C40H70O6 (646.517212)


   

DG(17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(17:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C40H70O6 (646.517212)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/17:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/17:0/0:0)

C40H70O6 (646.517212)


   

DG(17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(17:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C40H70O6 (646.517212)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/17:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/17:0)

C40H70O6 (646.517212)


   

DG(17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(17:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C40H70O6 (646.517212)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/17:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/17:0/0:0)

C40H70O6 (646.517212)


   

DG(17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(17:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C40H70O6 (646.517212)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/17:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/17:0)

C40H70O6 (646.517212)


   

DG(17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(17:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C40H70O6 (646.517212)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/17:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/17:0/0:0)

C40H70O6 (646.517212)


   

DG(17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(17:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C40H70O6 (646.517212)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/17:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/17:0)

C40H70O6 (646.517212)


   

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(17:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C40H70O6 (646.517212)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/17:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/17:0/0:0)

C40H70O6 (646.517212)


   

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(17:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C40H70O6 (646.517212)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/17:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/17:0)

C40H70O6 (646.517212)


   

cholesteryl 6-O-hexanoyl-beta-D-galactoside

cholesteryl 6-O-hexanoyl-beta-D-galactoside

C39H66O7 (646.4808286)


A cholesteryl 6-O-acyl-beta-D-galactoside having hexanoyl as the 6-O-acyl group.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(E)-2-(butanoylamino)-3-hydroxyhexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxyhexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C43H66O4 (646.4960836)


   

[(E)-2-(henicosanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(henicosanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(pentanoylamino)pentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)pentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(propanoylamino)heptacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)heptacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-2-(hexanoylamino)-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-2-acetamido-3-hydroxyoctacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxyoctacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(nonanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H66O4 (646.4960836)


   

[(E)-3-hydroxy-2-(octanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C43H66O4 (646.4960836)


   

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C43H66O4 (646.4960836)


   

[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C43H66O4 (646.4960836)


   

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H66O4 (646.4960836)


   

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C43H66O4 (646.4960836)


   

[(E)-2-(docosanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(docosanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-2-(heptanoylamino)-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(octadecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octadecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(undecanoylamino)nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(undecanoylamino)nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-2-(heptadecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptadecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-2-(decanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(decanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(icosanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(icosanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(nonadecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonadecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(tridecanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tridecanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(tetradecanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tetradecanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-3-hydroxy-2-(pentadecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentadecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E)-2-(hexadecanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexadecanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

N-(tridecanoyl)-4E-heptadecasphingenine-1-phosphocholine

N-(tridecanoyl)-4E-heptadecasphingenine-1-phosphocholine

C35H71N2O6P (646.5049475999999)


   

N-(tetradecanoyl)-4E-hexadecasphingenine-1-phosphocholine

N-(tetradecanoyl)-4E-hexadecasphingenine-1-phosphocholine

C35H71N2O6P (646.5049475999999)


   

N-(pentadecanoyl)-4E-pentadecasphingenine-1-phosphocholine

N-(pentadecanoyl)-4E-pentadecasphingenine-1-phosphocholine

C35H71N2O6P (646.5049475999999)


   

N-(hexadecanoyl)-4E-tetradecasphingenine-1-phosphocholine

N-(hexadecanoyl)-4E-tetradecasphingenine-1-phosphocholine

C35H71N2O6P (646.5049475999999)


   

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)hexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)hexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E,2R,3S)-2-(decanoylamino)-3-hydroxyicos-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2R,3S)-2-(decanoylamino)-3-hydroxyicos-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-carboxy-3-[2-decanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-decanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-dodecanoyloxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-dodecanoyloxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxyoctadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxyoctadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(E,2S,3R)-3-hydroxy-2-(tridecanoylamino)heptadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-3-hydroxy-2-(tridecanoylamino)heptadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxytetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxytetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)pentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)pentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-carboxy-3-[3-decanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-decanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(E,2R,3S)-2-(decanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2R,3S)-2-(decanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-carboxy-3-[3-dodecanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-dodecanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-decanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-decanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[hydroxy-[3-[(Z)-tetradec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(Z)-tetradec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[hydroxy-[2-nonanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-nonanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[carboxy-[2-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

2-[carboxy-[2-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-decoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[3-nonoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-nonoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[2-propanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-propanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-decanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-decanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-heptanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

N-(dodecanoyl)-sphing-4-enine-1-phosphocholine

N-(dodecanoyl)-sphing-4-enine-1-phosphocholine

C35H71N2O6P (646.5049475999999)


   

N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine

N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


A ceramide phosphoethanolamine (33:1) in which the sphingoid and acyl components are pentadecasphing-4-enine and octadecanoyl respectively.

   

1-(1Z-hexadecenyl)-2-heptadecanoyl-glycero-3-phosphate

1-(1Z-hexadecenyl)-2-heptadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

1-hexadecyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

1-hexadecyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H71O7P (646.4937146)


   

ceramide phosphoethanolamine (33:1)

ceramide phosphoethanolamine (33:1)

C35H71N2O6P (646.5049475999999)


A ceramide phosphoethanolamine in which the sphingoid base and acyl group contains a total of 33 carbon atoms and 1 double bond.

   

N-lauroylsphingosine-1-phosphocholine

N-lauroylsphingosine-1-phosphocholine

C35H71N2O6P (646.5049475999999)


A sphingomyelin d18:1 in which the ceramide N-acyl group is specified as dodecanoyl (lauroyl).

   

MGDG(27:0)

MGDG(12:0(1)_15:0)

C36H70O9 (646.5019570000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

SM(d18:1_12:0)

SM(d18:1_12:0)

C35H71N2O6P (646.5049475999999)


PANOMIX internal lipid standards

   

MGMG(27:0)

MGMG(27:0)

C36H70O9 (646.5019570000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 17:2/O-26:7

FAHFA 17:2/O-26:7

C43H66O4 (646.4960836)


   

FAHFA 17:3/O-26:6

FAHFA 17:3/O-26:6

C43H66O4 (646.4960836)


   

FAHFA 17:4/O-26:5

FAHFA 17:4/O-26:5

C43H66O4 (646.4960836)


   

FAHFA 17:5/O-26:4

FAHFA 17:5/O-26:4

C43H66O4 (646.4960836)


   

FAHFA 18:2/O-25:7

FAHFA 18:2/O-25:7

C43H66O4 (646.4960836)


   

FAHFA 18:3/O-25:6

FAHFA 18:3/O-25:6

C43H66O4 (646.4960836)


   

FAHFA 18:4/O-25:5

FAHFA 18:4/O-25:5

C43H66O4 (646.4960836)


   

FAHFA 18:5/O-25:4

FAHFA 18:5/O-25:4

C43H66O4 (646.4960836)


   

FAHFA 18:6/O-25:3

FAHFA 18:6/O-25:3

C43H66O4 (646.4960836)


   

FAHFA 19:2/O-24:7

FAHFA 19:2/O-24:7

C43H66O4 (646.4960836)


   

FAHFA 19:3/O-24:6

FAHFA 19:3/O-24:6

C43H66O4 (646.4960836)


   

FAHFA 19:4/O-24:5

FAHFA 19:4/O-24:5

C43H66O4 (646.4960836)


   

FAHFA 19:5/O-24:4

FAHFA 19:5/O-24:4

C43H66O4 (646.4960836)


   

FAHFA 19:6/O-24:3

FAHFA 19:6/O-24:3

C43H66O4 (646.4960836)


   

FAHFA 20:2/O-23:7

FAHFA 20:2/O-23:7

C43H66O4 (646.4960836)


   

FAHFA 20:3/O-23:6

FAHFA 20:3/O-23:6

C43H66O4 (646.4960836)


   

FAHFA 20:4/O-23:5

FAHFA 20:4/O-23:5

C43H66O4 (646.4960836)


   

FAHFA 20:5/O-23:4

FAHFA 20:5/O-23:4

C43H66O4 (646.4960836)


   

FAHFA 20:6/O-23:3

FAHFA 20:6/O-23:3

C43H66O4 (646.4960836)


   

FAHFA 21:2/O-22:7

FAHFA 21:2/O-22:7

C43H66O4 (646.4960836)


   

FAHFA 21:3/O-22:6

FAHFA 21:3/O-22:6

C43H66O4 (646.4960836)


   

FAHFA 21:4/O-22:5

FAHFA 21:4/O-22:5

C43H66O4 (646.4960836)


   

FAHFA 21:5/O-22:4

FAHFA 21:5/O-22:4

C43H66O4 (646.4960836)


   

FAHFA 21:6/O-22:3

FAHFA 21:6/O-22:3

C43H66O4 (646.4960836)


   

FAHFA 21:7/O-22:2

FAHFA 21:7/O-22:2

C43H66O4 (646.4960836)


   

FAHFA 22:2/O-21:7

FAHFA 22:2/O-21:7

C43H66O4 (646.4960836)


   

FAHFA 22:3/O-21:6

FAHFA 22:3/O-21:6

C43H66O4 (646.4960836)


   

FAHFA 22:4/O-21:5

FAHFA 22:4/O-21:5

C43H66O4 (646.4960836)


   

FAHFA 22:5/O-21:4

FAHFA 22:5/O-21:4

C43H66O4 (646.4960836)


   

FAHFA 22:6/O-21:3

FAHFA 22:6/O-21:3

C43H66O4 (646.4960836)


   

FAHFA 22:7/O-21:2

FAHFA 22:7/O-21:2

C43H66O4 (646.4960836)


   

FAHFA 23:3/O-20:6

FAHFA 23:3/O-20:6

C43H66O4 (646.4960836)


   

FAHFA 23:4/O-20:5

FAHFA 23:4/O-20:5

C43H66O4 (646.4960836)


   

FAHFA 23:5/O-20:4

FAHFA 23:5/O-20:4

C43H66O4 (646.4960836)


   

FAHFA 23:6/O-20:3

FAHFA 23:6/O-20:3

C43H66O4 (646.4960836)


   

FAHFA 23:7/O-20:2

FAHFA 23:7/O-20:2

C43H66O4 (646.4960836)


   

FAHFA 24:3/O-19:6

FAHFA 24:3/O-19:6

C43H66O4 (646.4960836)


   

FAHFA 24:4/O-19:5

FAHFA 24:4/O-19:5

C43H66O4 (646.4960836)


   

FAHFA 24:5/O-19:4

FAHFA 24:5/O-19:4

C43H66O4 (646.4960836)


   

FAHFA 24:6/O-19:3

FAHFA 24:6/O-19:3

C43H66O4 (646.4960836)


   

FAHFA 24:7/O-19:2

FAHFA 24:7/O-19:2

C43H66O4 (646.4960836)


   

FAHFA 25:3/O-18:6

FAHFA 25:3/O-18:6

C43H66O4 (646.4960836)


   

FAHFA 25:4/O-18:5

FAHFA 25:4/O-18:5

C43H66O4 (646.4960836)


   

FAHFA 25:5/O-18:4

FAHFA 25:5/O-18:4

C43H66O4 (646.4960836)


   

FAHFA 25:6/O-18:3

FAHFA 25:6/O-18:3

C43H66O4 (646.4960836)


   

FAHFA 25:7/O-18:2

FAHFA 25:7/O-18:2

C43H66O4 (646.4960836)


   

FAHFA 26:4/O-17:5

FAHFA 26:4/O-17:5

C43H66O4 (646.4960836)


   

FAHFA 26:5/O-17:4

FAHFA 26:5/O-17:4

C43H66O4 (646.4960836)


   

FAHFA 26:6/O-17:3

FAHFA 26:6/O-17:3

C43H66O4 (646.4960836)


   

FAHFA 26:7/O-17:2

FAHFA 26:7/O-17:2

C43H66O4 (646.4960836)


   
   
   
   
   
   
   
   
   
   
   
   

PA P-14:0/19:0 or PA O-14:1/19:0

PA P-14:0/19:0 or PA O-14:1/19:0

C36H71O7P (646.4937146)


   
   

PA P-16:0/17:0 or PA O-16:1/17:0

PA P-16:0/17:0 or PA O-16:1/17:0

C36H71O7P (646.4937146)


   
   

PA P-18:0/15:0 or PA O-18:1/15:0

PA P-18:0/15:0 or PA O-18:1/15:0

C36H71O7P (646.4937146)


   
   

PA P-20:0/13:0 or PA O-20:1/13:0

PA P-20:0/13:0 or PA O-20:1/13:0

C36H71O7P (646.4937146)


   
   

PA P-22:0/11:0 or PA O-22:1/11:0

PA P-22:0/11:0 or PA O-22:1/11:0

C36H71O7P (646.4937146)


   
   

PA P-33:0 or PA O-33:1

PA P-33:0 or PA O-33:1

C36H71O7P (646.4937146)